The Mundipharma network of independent associated companies has announced Alberto Martinez as the newly-appointed President and Chief Executive Officer of Mundipharma International.
Alberto started his career in pharmaceutical sales in Spain before joining the Mundipharma network in 2003. Over the last 14 years he has transitioned through roles of increased leadership responsibility including General Manager of Mundipharma in Spain, where he led a corporate turnaround between 2008 and 2014, leading the company to achieve number 1 status in Great Places to Work where it remains to date. He has also led the UK commercial organization in the network, Napp Pharmaceuticals Ltd, where he drove a robust transformation program resulting in significant growth, including achieving market leadership for infliximab biosimilar, Remsima. He was also given additional responsibility as Regional Director of Northern Europe before being appointed most recently in October 2016 as European Director of Commercial Operations.
